All News


All series


All All News

Stress Cardiovascular MRI: What a New Meta-Analysis Reveals

For the detection of obstructive coronary artery disease (CAD), stress cardiovascular magnetic resonance imaging (MRI) demonstrated a sensitivity rate of 81 percent and a specificity rate of 86 percent, according to a meta-analysis of 64 studies and data from 74,470 patients with stable chest pain.

MRI Findings Show Vorasidenib More Than Doubles Progression-Free Survival in Patients with Grade 2 IDH Gliomas

For patients with residual or recurrent grade 2 isocitrate dehydrogenase (IDH)-mutant gliomas, magnetic resonance imaging (MRI) revealed that daily dosing of vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes, led to a median progression-free survival of 27.7 months in comparison to 11.1 months in a placebo group, according to new research presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

FDA Approves New PSMA PET Agent POSLUMA for Prostate Cancer Imaging

Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum prostate-specific antigen (PSA) level.

Are You Prone to Superstitions in Radiology?

Whether it’s the proverbial “bad penny” case that crashes PACS or the perception that positive computed tomography angiography (CTA) exams for pulmonary arterial clots come in sets of three, suspicions can emerge here and there in radiology.

Can Abbreviated MRI Have an Impact in Neuroimaging?

In a recently published review, radiology researchers from the University of Wisconsin discussed the potential and key considerations for applying accelerated magnetic resonance imaging (MRI) protocols in the assessment of emergent and urgent conditions.